124 -11 (73) 2024 - Tursunov R.S., Juraeva Kh.I. - ATRIAL FIBRILLATION IN PATIENTS WITH OBESITY AND ARTERIAL HYPERTENSION

ATRIAL FIBRILLATION IN PATIENTS WITH OBESITY AND ARTERIAL HYPERTENSION

Tursunov R.S. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Juraeva Kh.I. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

We conducted a study on 184 working-aged male police officers who have been diagnosed with arterial hypertension (AH). Our findings revealed that obesity in this cohort significantly raises the occurrence of atrial fibrillation. Furthermore, we identified a direct correlation between the severity of arrhythmia and the extent of obesity. The primary risk factors for atrial fibrillation in obese men include AH stages II-III, dilation of the left ventricle and left atrium, low serum levels of high-density lipoproteins, and an abnormal blood pressure profile (non-dipper type). No connection was found between atrial fibrillation, age, and ischemic heart disease in these obese patients.

Key words: arterial hypertension, obesity, atrial fibrillation

First page

712

Last page

714

For citation:Tursunov R.S., Juraeva Kh.I. - ATRIAL FIBRILLATION IN PATIENTS WITH OBESITY AND ARTERIAL HYPERTENSION//New Day in Medicine 11(73)2024 712-714 https://https://newdayworldmedicine.com/en/new_day_medicine/11-73-2024

List of References

  1. Diagnosis and treatment of atrial fibrillation. Recommendations of the RKO, VNOA, and ACCS. Moscow. 2012; 100 p.
  2. Sidorova N.V., Solovyanova E.N., Nosov V.P., Furmenkova Y.V., Malysheva E.B. Daily monitoring of arterial pressure in clinical practice. Nizhny Novgorod. 2000; 34 p.
  3. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society). Circulation. 2005; 112: e154-e235.
  4. Feinberg W.M., Cornell E.S., Nightingale S.D. et al. For the Stroke Prevention in Atrial Fibrillation Investigators. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke. 1997; 28: 1101−1106.
  5. Fuster V. et al. ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation. J. Am. Coll. Cardiol. 2001; 38: 1266i−1xx.
  6. Kopecky S.L., Gersh B.J., McGoon M.D. et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N. Engl. J. Med. 1987; 317: 669−674.
  7. Narkiewicz K. Obesity and hypertension — the issue is more complex than we thought. Nephrol. Dial. Transplant. 2006; 21(2): 264-267.
  8. Prystowsky E.N., Katz A.M. Atrial fibrillation. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott-Raven. 1998: 1827−1861.
  9. Thomas F., Bean K., Pannier B. et al. Cardiovascular mortality in overweight subjects. The key role of associated risk factors. Hypertension. 2005; 46: 654-663.
  10. Unger R.H. Lipotoxic diseases. Annu. Rev. Med. 2002; 53: 319-336.
  11. Unger R.H., Scherer P.E. Gluttony, sloth, and metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol. Metab. 2010; 21(6): 345-352.

    file

    download